Dr Deepak Kumar, Audiology Clinic has partnered with Neuromod Devices Ltd to provide Lenire®, the first commercially available bimodal neuromodulation device shown in large-scale clinical trials, to reduce the symptoms and improve the experience of those living with tinnitus

Lenire is a non-invasive home-use medical device that has CE-mark certification for the treatment of tinnitus under the supervision of an appropriately qualified healthcare professional.

What is Lenire?

Lenire is a non-invasive medical device that uses bimodal neuromodulation to treat tinnitus symptoms.

Lenire delivers mild electrical pulses to the tongue combined with sound played through headphones to drive long-term changes or neuroplasticity in the brain to treat tinnitus. The device is fitted and used in accordance with a tailored treatment plan prescribed by an appropriately qualified healthcare professional, such as an audiologist or ENT surgeon.

How Lenire Soothes Tinnitus

Lenire applies bimodal neuromodulation, the pairing of mild electrical stimulation to the tongue with sound stimulation. This pairing works to retrain neurons in the brain to reduce its attention and sensitivity to the tinnitus sound.

Lenire and Clinical trials

The Lenire tinnitus treatment device was proven to soothe tinnitus symptoms in clinical trials involving more than 500 patients.

The largest of these, TENT-A1, showed that 86.2% of compliant participants reported improvement in their Tinnitus Handicap Inventory score after 12 weeks of treatment. 80.1% of participants who used Lenire as directed in this trial achieved an improvement of their Tinnitus Handicap Inventory score that was sustained for 12 months after treatment.

The TENT-A1 trial involved 326 participants and was published in Science Translational Medicine in October 2020 (https://www.science.org/doi/10.1126/scitranslmed.abb2830)

How do I get Lenire?

Lenire is available for use on prescription and under the supervision of a qualified healthcare professional.

At The Audiology Clinic,Dr Deepak Kumar, Audiological Scientist will evaluate your tinnitus and determine if Lenire is right for you. If Lenire is recommended, we will prescribe a treatment plan that typically includes daily 30-minute sessions and at least two follow up visits with the first approximately 6 to 12 weeks after you start using Lenire and the second 6 to 12 weeks after your first follow up.

During these follow up visits your clinician may adjust device settings to optimise the potential for relief.

Lenire facts

86.2%

86.2% of compliant TENT-A1 participants reported improvement in their THI score after 12 weeks of treatment

80.1%

80.1% of compliant TENT-A1 participants reported improvement in their THI score that continued for 12 months after treatment ended

500+

Neuromod has invested in clinical trials involving more than 500 participants